title: [Cost of vaccination and cost of sick leave are determinants of cost-effectiveness vaccination against rotavirus].
abstract: The literature on cost-effectiveness of oral vaccination against rotavirus infection in high-income European countries is assessed in order to show which parameters are important for evaluation results and recommendations on inclusion in child immunization programs. There is a high degree of variation in results due to variation in country specific incidence rates, unit costs and assumed price of the vaccination. A determining factor is whether only costs to the health care system are included or whether a broader approach to costing is applied. A Danish discussion on this issue is pivotal.
authors.affiliation: Institut for Sundhedstjenesteforskning, Syddansk Universitet, Denmark.
authors.forename: Dorte
authors.initials: D
authors.lastname: Gyrd-Hansen
authors.forename: Kim Rose
authors.initials: KR
authors.lastname: Olsen
mesh_terms: D003362:Cost-Benefit Analysis; D003718:Denmark; D003968:Diarrhea, Infantile / Q000517:prevention & control / Q000821:virology; D005060:Europe; D006291:Health Policy; D006801:Humans; D007223:Infant; D032541:Mass Vaccination / Q000191:economics*; D012400:Rotavirus Infections / Q000191:economics* / Q000517:prevention & control; D022243:Rotavirus Vaccines / Q000191:economics*; D018582:Sick Leave / Q000191:economics*
chemical_list: D022243:Rotavirus Vaccines